MetaVia Presents Pre-Clinical Data on DA-1241 Demonstrating Additive Hepatoprotective Effects in Combination With Efruxifermin at the ADA's 85th Scientific Session – RP Digital

Business

MetaVia Presents Pre-Clinical Data on DA-1241 Demonstrating Additive Hepatoprotective Effects in Combination With Efruxifermin at the ADA's 85th Scientific Session

June 21, 20251 min0

MetaVia Presents Pre-Clinical Data on DA-1241 Demonstrating Additive Hepatoprotective Effects in Combination With Efruxifermin at the ADA's 85th Scientific Session

Source link

rpdigital

Leave a Reply Cancel reply

Related Articles

Akzo Nobel to sell Indian unit to JSW Group for $1.6 bln, will buy back shares

rpdigitalJune 27, 20250